Independent Medical Education Grant for Guideline Concordant Care in Muscle Invasive Bladder Cancer (MIBC)

Pfizer Inc. invites applications for its Independent Medical Education Grant focused on improving guideline concordant care and utilizing new data for patients with Muscle Invasive Bladder Cancer (MIBC) and locally advanced or metastatic Urothelial Carcinoma (la/mUC). This competitive grant program aims to address gaps in awareness, knowledge, and application of treatment guidelines among healthcare professionals in the United States. The submission deadline for proposals is 10 November 2026. This grant program is designed to enhance the understanding and implementation of treatment strategies for MIBC and la/mUC among healthcare professionals. The initiative seeks to bridge educational gaps by focusing on the limitations of current treatments and the potential of new therapeutic options, including antibody-drug conjugates. It emphasizes the importance of shared decision-making and multidisciplinary approaches in optimizing patient care. This grant supports initiatives that aim to enhance the care of patients with MIBC and la/mUC by educating healthcare professionals on the latest treatment guidelines and innovations. By addressing current gaps in knowledge and practice, the program seeks to improve patient outcomes and advance the standard of care within the urology and oncology fields. Who can apply for this grant? Eligible applicants include educational institutions, healthcare organizations, and other entities focused on healthcare education within the United States. What is the funding range for individual projects? Projects can request funding between $10,000 and $230,000. What should the project proposal include? The proposal should outline the project’s goals, objectives, need assessment, target audience, design, innovation, evaluation plan, and budget details. What is the deadline for submission? Applications must be submitted by 10 November 2026, 23:59 EST. How will applicants be notified of their grant status? Applicants will receive notifications via email by 30 November 2026. Eligible organizations are encouraged to review the official guidelines and follow the detailed application process through the Pfizer grant portal. For further information, refer to the Pfizer Competitive Grant Program User Guide.